Related Experiment Video

Updated: Jun 15, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Diabetic cardiomyopathy: signaling defects and therapeutic approaches

Joseph S Dobrin1, Djamel Lebeche

  • 1Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY 10029, USA. joseph.dobrin@mssm.edu

Expert Review of Cardiovascular Therapy
|March 13, 2010
PubMed

Insights

Diabetic cardiomyopathy, a heart failure complication in diabetes mellitus, stems from complex metabolic and cellular issues. Understanding these factors is key to developing new treatments for this growing global health concern.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is a rapidly progressing global disease with significant mortality, often linked to heart failure.
  • Diabetic cardiomyopathy is a specific heart dysfunction in diabetics, separate from other common causes like hypertension or coronary artery disease.
  • The development of diabetic cardiomyopathy involves intricate pathological pathways.

Purpose of the Study:

  • To elucidate the complex pathogenesis of diabetic cardiomyopathy.
  • To discuss the impact of key contributing factors in diabetic cardiomyopathy.
  • To review current and novel therapeutic strategies for diabetic cardiomyopathy.

Main Methods:

  • Review of existing literature on diabetic cardiomyopathy.
  • Analysis of the roles of dysregulated lipid metabolism, insulin resistance, and mitochondrial dysfunction.
  • Examination of adipokine signaling pathways and their contribution to cardiac dysfunction.

Main Results:

  • Diabetic cardiomyopathy is characterized by impaired lipid metabolism, insulin resistance, and mitochondrial dysfunction.
  • Disturbances in adipokine secretion and signaling significantly contribute to the disease.
  • These metabolic and cellular abnormalities lead to disrupted calcium homeostasis, causing lusitropic and inotropic defects.

Conclusions:

  • The pathogenesis of diabetic cardiomyopathy is multifactorial, involving metabolic, cellular, and signaling disruptions.
  • Targeting these specific pathways offers potential for therapeutic intervention.
  • Further research into available and emerging treatments is crucial for managing diabetic cardiomyopathy.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...